KALA BIO (KALA) News Today $10.59 +0.94 (+9.74%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$10.16 -0.43 (-4.01%) As of 08/28/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KALA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period HC Wainwright Has Positive Estimate for KALA BIO Q3 EarningsAugust 17, 2025 | marketbeat.comKALA BIO, Inc.: KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 8, 2025 | finanznachrichten.deKALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 8, 2025 | globenewswire.comKALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual ConferenceAugust 6, 2025 | globenewswire.comKALA BIO (KALA) to Release Earnings on TuesdayJuly 30, 2025 | marketbeat.comKALA BIO (NASDAQ:KALA) Upgraded by Wall Street Zen to Hold RatingJuly 28, 2025 | marketbeat.comKALA BIO Announces Completion of Enrollment in CHASE Clinical Trial ...July 11, 2025 | morningstar.comMKALA BIO Completes Patient Enrollment in CHASE Phase 2b Trial ... - NasdaqJuly 11, 2025 | nasdaq.comKALA BIO Inc. (KALA) Stock Price Today - WSJ - The Wall Street JournalJuly 10, 2025 | wsj.comKALA BIO, Inc.: KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)July 9, 2025 | finanznachrichten.deKala Pharmaceuticals Completes Enrollment for Phase 2b TrialJuly 9, 2025 | tipranks.comKALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)July 9, 2025 | globenewswire.comKala Bio Inc Valuation - MorningstarJuly 8, 2025 | morningstar.comMKALA BIO, Inc. (KALA) - Yahoo FinanceJuly 1, 2025 | finance.yahoo.comKALA BIO, Inc. (NASDAQ:KALA) CFO Sells $14,560.31 in StockJune 27, 2025 | insidertrades.comMary Reumuth Sells 2,850 Shares of KALA BIO, Inc. (NASDAQ:KALA) StockJune 5, 2025 | insidertrades.comKALA BIO to Present at Jefferies Global Healthcare ConferenceMay 29, 2025 | globenewswire.comKALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 14, 2025 | finance.yahoo.comKALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateMarch 31, 2025 | markets.businessinsider.comKALA BIO to Present at TD Cowen 45th Annual Health Care ConferenceFebruary 26, 2025 | finance.yahoo.comKALA BIO's (KALA) "Buy" Rating Reiterated at HC WainwrightFebruary 13, 2025 | marketbeat.comKala Bio announces CEO departure, appoints interim leaderFebruary 12, 2025 | msn.comKALA BIO, Inc.: KALA BIO Announces Chief Executive Officer TransitionFebruary 12, 2025 | finanznachrichten.deKala Bio appoints new interim CEO amid leadership shuffleFebruary 12, 2025 | msn.comKala announces resignation of CEO Iwicki, Bazemore appointed interim CEOFebruary 12, 2025 | markets.businessinsider.comKala Bio Stock Sinks On CEO Exit, But Retail Feels It’s An OverreactionFebruary 12, 2025 | msn.comKALA BIO Announces Chief Executive Officer TransitionFebruary 12, 2025 | globenewswire.comKALA BIO, Inc. (NASDAQ:KALA) Short Interest UpdateFebruary 2, 2025 | marketbeat.comKALA stock soars to 52-week high, reaching $8.81January 29, 2025 | msn.comKala Pharmaceuticals files to sell 1.67M shares of common stock for holdersJanuary 24, 2025 | markets.businessinsider.comKALA BIO, Inc. (NASDAQ:KALA) CFO Sells $13,016.78 in StockJanuary 8, 2025 | insidertrades.comBros. Advisors Lp Baker Purchases 310,559 Shares of KALA BIO, Inc. (NASDAQ:KALA) StockJanuary 1, 2025 | insidertrades.comKALA BIO Announces $10,750,000 Private PlacementDecember 30, 2024 | globenewswire.comKALA BIO to Present at Piper Sandler 36th Annual Healthcare ConferenceNovember 27, 2024 | globenewswire.comTravis Kelce's Ex-Girlfriend Steps Out With Travis Scott at Strip ClubNovember 14, 2024 | msn.comKala Bio Advances PCED Treatment Amid Financial UpdateNovember 14, 2024 | markets.businessinsider.comKALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 12, 2024 | finance.yahoo.com28 Products With Results That Are Truly Worth CelebratingOctober 30, 2024 | msn.comTravis Kelce's Ex Stirs Up Drama With Another TaylorOctober 15, 2024 | msn.comTaylor Swift Fans Rush to Support Caitlin Clark After Angel Reese Interviews Travis Kelce's ExOctober 13, 2024 | msn.comThis new biography about architect Charles Correa explores his visionary geniusOctober 12, 2024 | msn.comAthlos, new women’s track venture, plans future event after drawing 3 million viewersOctober 11, 2024 | nytimes.comObama, the ‘hopey-changey guy,’ tries to close the deal for HarrisOctober 11, 2024 | msn.comNorth West Puts Mom Kim Kardashian on Blast for Not Cooking for Their FamilyOctober 11, 2024 | newsweek.comNBiohacking: This Couple Plans To Live Until 150 Years Using This Increasingly Popular Wellness Trend. Find Out MoreOctober 6, 2024 | msn.comUFC 307 social media reactions: Kayla Harrison's bloody win over Ketlen Vieira leads to calls for title shotOctober 6, 2024 | mmajunkie.usatoday.comKala Bio (NASDAQ:KALA) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.com‘Biohacking’ couple plans to live longer than anyone on the planet — check out their daily routineOctober 3, 2024 | nypost.comN37 Beauty Products That Only Cost A *Little* (But You'll Use Them A *Lot*)September 30, 2024 | msn.comHow Costco Became Involved in Diddy's Sex Crimes CaseSeptember 28, 2024 | newsweek.comN Get KALA BIO News Delivered to You Automatically Sign up to receive the latest news and ratings for KALA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KALA Media Mentions By Week KALA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KALA News Sentiment▼1.871.03▲Average Medical News Sentiment KALA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KALA Articles This Week▼11▲KALA Articles Average Week Get the Latest News and Ratings for KALA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for KALA BIO and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Annexon News Today Prima BioMed News Today Humacyte News Today SOPHiA GENETICS News Today ProQR Therapeutics News Today Alector News Today Adherex Technologies News Today Entrada Therapeutics News Today Tiziana Life Sciences News Today Sagimet Biosciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KALA) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KALA BIO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KALA BIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access